"On March 10, 2017, the Company’s board of directors

New Post Public Reply Private Reply Replies (1) Message Board
Bornet
420
"On March 10, 2017, the Company’s board of directors approved a change in the Company's fiscal year end from January 31 st to December 31 st , effective immediately. The required transition period of February 1, 2016 to December 31, 2016 is included in the financial statements set forth in this report. The Company presently has no revenues and minimal assets, and accordingly, the Company may be deemed to be a shell company. The Company is currently reviewing business opportunities, including the potential to enter into a reverse merger transaction . At the present time, the Company has not yet entered into any agreement for such transaction.

At the present time we have two officers, our Chief Executive Officer Conn Flanigan and our Chief Financial Officer Rongguo (Ronald) Wei. Our board of directors includes Mr. Flanigan and Fai H. Chan, the Chief Executive Officer of Singapore eDevelopment, our largest shareholder. We have no employees as of the date of this Report."

https://www.otcmarkets.com/edgar/GetFilingHtm...D=11962693

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Innovative Veterinary Software Enhancements by Weave Simplified

Updated Category News Views 247

Weave Enhancements Tailored for Veterinary Practices Weave, a prominent player in the customer experience and payments software arena, has recently made significant improvements aimed specifically at veterinary clinics. The updates are the result of thorough feedback from veterinary professionals, designed to enhance operational workflows and significantly improve client...

Continue Reading
Recursion Pharmaceuticals Earnings: What Investors Should Know

Updated Category News Views 203

Eyes on the Earnings: Recursion Pharmaceuticals’ Upcoming Report The air is thick with anticipation as Recursion Pharmaceuticals (NASDAQ: RXRX) prepares to unveil its latest quarterly earnings this coming Wednesday, February 25, 2026. Investors are itching to dissect every line of the release for tidbits that could shape their strategies moving forward. EPS...

Continue Reading
Middlefield Banc Corp's CEO Invests $6K, Reflecting Confidence

Updated Category News Views 68

Middlefield Banc Corp's CEO Makes a Notable Stock Purchase Recently, Ronald Len Zimmerly Jr., the CEO of Middlefield Banc Corp (NASDAQ: MBCN), drew attention by boosting his investment in the company. He bought shares worth approximately $6,000, acquiring 212.283 shares at a price of $28.47 each. After this transaction, Zimmerly now holds a total of 31,289.283 shares of...

Continue Reading
Exploring Sandbox VR's Exciting New Franchise Partnership

Updated Category News Views 106

Sandbox VR Expands Its Franchise Network Sandbox VR, the leader in premium location-based virtual reality experiences, is set to grow its horizons by partnering with LOL Entertainment. This exciting collaboration aims to introduce Sandbox VR locations in several prominent East Coast cities, enhancing the entertainment scene with innovative virtual reality experiences. New...

Continue Reading
Investors May Engage in Semler Scientific, Inc. Lawsuit

Updated Category News Views 178

Understanding the Semler Scientific, Inc. Lawsuit Investors have been alerted of an upcoming class action lawsuit against Semler Scientific, Inc. regarding allegations of securities fraud. The law firm spearheading this action, The Schall Law Firm, is committed to representing those who have been affected and encouraging participation from shareholders. What Are the...

Continue Reading